Denali Therapeutics DNLI
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–
DNLI Stock News
Headlines matching Denali Therapeutics or the DNLI ticker, most recent first.
- A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $42
- A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $41
- B. Riley Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 Positive
- J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $29
- Morgan Stanley Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $36 Positive
- Deutsche Bank Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 Positive
- BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Announces Target Price $31
- J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $29 Positive
- H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $42
- Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $26 Positive
- UBS Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $25
- William Blair Maintains Denali Therapeutics(DNLI.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), CG Oncology, Inc. (CGON) and Denali Therapeutics (DNLI)
- TD Cowen Maintains Denali Therapeutics(DNLI.US) With Buy Rating
- Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Cuts Target Price to $23 Negative
No comments yet — be the first to weigh in on DNLI.
Sign in to join the discussion.